Back to News
Market Impact: 0.3

The Implied Analyst 12-Month Target For EPS

EPSAMTMCLHTXTNDAQHCATSWVL
Analyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
The Implied Analyst 12-Month Target For EPS

The WisdomTree U.S. LargeCap Fund ETF (EPS) has an implied analyst target price of $69.30, indicating an 11.85% upside from its recent trading price of $61.96, based on the weighted average analyst targets of its underlying holdings. Key contributors to this projected upside include Amentum Holdings Inc (AMTM) with 15.49% potential upside, Clean Harbors Inc (CLH) with 13.14% upside, and Textron Inc (TXT) with 12.64% upside to their respective average analyst targets.

Analysis

An analysis of the WisdomTree U.S. LargeCap Fund ETF (EPS) indicates a potential 11.85% upside, with an implied analyst target price of $69.30 per unit compared to its recent trading price of $61.96. This implied target is a weighted average derived from the 12-month forward price targets of the ETF's underlying holdings. Notably, key holdings such as Amentum Holdings (AMTM), Clean Harbors (CLH), and Textron (TXT) exhibit significant potential upside to their respective analyst targets at 15.49%, 13.14%, and 12.64%. However, the analysis is accompanied by a cautionary tone, questioning whether these analyst targets are justifiably optimistic or simply outdated. The divergence between current trading prices and high analyst targets suggests a need for deeper scrutiny, as such targets could be precursors to future downgrades if company or industry fundamentals have recently shifted, a point that requires further investor due diligence.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.05

Ticker Sentiment

AMTM0.50
CLH0.50
EPS0.40
HCAT0.00
NDAQ0.00
SWVL0.00
TXT0.50

Key Decisions for Investors

  • Investors could consider the 11.85% implied upside in the EPS ETF as a catalyst for further research into its key holdings, particularly AMTM, CLH, and TXT, to validate the bullish analyst sentiment.